Express Scripts Holding Company
(NASDAQ: ESRX)
62.76
-0.18
-0.29%
-0.18
-0.29%
MORE ON ESRX
COMPANY INFORMATION
| Exchange: | NASDAQ national market |
| Stock: | Express Scripts |
| Industry: | Healthcare Plans |
| Employees: | 30,215 |
DESCRIPTION
| Express Scripts, Inc. was incorporated in Missouri in September 1986, and reincorporated in Delaware in March 1992. It operates as a Pharmacy benefit management in North America, offering a full range of services to its clients, which include HMOs, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It helps health benefit providers address access and affordability concerns resulting from rising drug costs while helping to improve healthcare outcomes. The Company manages the cost of the drug benefit by performing the following functions: evaluating drugs for price, value and efficacy in order to assist clients in selecting a cost-effective formulary; leveraging purchasing volume to deliver discounts to health benefit providers; promoting the use of generics and low-cost brands; and offering cost-effective home delivery pharmacy and specialty services which result in drug cost savings for plan sponsors and co-payment savings for members. It works with clients, manufacturers, pharmacists and physicians to increase efficiency in the drug distribution chain, to manage costs in the pharmacy benefit and to improve members’ health outcomes and satisfaction. In an effort to deliver a superior clinical offering which targets the reduction of waste and the improvement of health outcomes, it applies a unique behavior-centric approach to changing consumer behavior which it calls Consumerology®. It has organized its operations into two business segments based on products and services offered: PBM and Emerging Markets. The Company’s PBM segment primarily consists of the following services: retail network pharmacy management and retail drug card programs; home delivery services; specialty benefit services; patient care contact centers; benefit plan design and consultation; drug formulary management, compliance and therapy management programs; information reporting and analysis programs; rebate programs; electronic claims processing and drug utilization review; administration of a group purchasing organization; consumer health and drug information; bio-pharma services including reimbursement and customized logistics solutions; improved health outcomes through personalized medicine and application of pharmacogenomics; and assistance programs for low-income patients. The EM segment primarily consists of the following services: distribution of pharmaceuticals and medical supplies to providers and clinics; and healthcare account administration and implementation of consumer-directed healthcare solutions. |
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
RECENT QUOTES
WATCHLIST
You're not signed in
You’re not signed in to MSN Money, so you’re seeing the Watchlist that is tied to your computer. For a more consistent Watchlist experience, sign in to MSN Money.
Learn more
Sponsored by:
MARKET UPDATE
[BRIEFING.COM] The major averages continue to hover near their lows with the S&P 500 off by 0.2%. Yesterday's top performer, the industrial sector, is among the early laggards today as defense companies lag. General Electric (GE 24.15, -0.18) trades
...
More
MORE MARKET NEWS
Sponsored by: